Omid Farokhzad
Directeur Général chez SEER, INC.
Fortune : 9 M $ au 30/04/2024
Profil
Fondateur de 5 sociétés différentes, parmi lesquelles : Seer, Inc. (Californie), Selecta Biosciences, Inc. et DNIB Unwind, Inc. Omid C. Farokhzad est un entrepreneur et est président-directeur général de Seer, Inc. (Californie) (qu'il a fondée en 2017). Il est également membre du conseil d'administration de Placon Therapeutics, Inc. Dans sa carrière antérieure, il a été président du conseil d'administration de Selecta Biosciences, Inc. (il a fondé la société en 2007), professeur associé à la Harvard Medical School, directeur chez DNIB Unwind, Inc. et directeur chez Tarveda Therapeutics, Inc. Le Dr Farokhzad a obtenu un doctorat et un diplôme d'études supérieures de la faculté de médecine de l'université de Boston et un MBA du Massachusetts Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SEER, INC.
87,67% | 31/12/2023 | 3 555 195 ( 87,67% ) | 6 M $ | 30/04/2024 |
SEER, INC. CLASS A
2,37% | 07/03/2024 | 1 436 285 ( 2,37% ) | 3 M $ | 30/04/2024 |
SENTI BIOSCIENCES, INC.
4,26% | 13/05/2024 | 1 947 403 ( 4,26% ) | 543 325 $ | 30/04/2024 |
Postes actifs de Omid Farokhzad
| Sociétés | Poste | Début |
|---|---|---|
| SEER, INC. | Directeur Général | 01/03/2018 |
| SENTI BIOSCIENCES, INC. | Directeur/Membre du Conseil | 08/06/2022 |
Placon Therapeutics, Inc.
 Placon Therapeutics, Inc. BiotechnologyHealth Technology Placon Therapeutics, Inc. develops novel platinum therapies. The private company is based in Watertown. | Directeur/Membre du Conseil | - |
| Xlink Therapeutics, Inc. | Fondateur | - |
PrognomIQ, Inc.
 PrognomIQ, Inc. Medical SpecialtiesHealth Technology PrognomIQ, Inc. operates as a healthcare company, which engages in the development and commercialization of multi-omics human tests for cancer and other complex diseases. It aims to leverage Seer’s Proteograph in addition to genomics and metabolomics technologies, to develop multi-omics products to improve human health. The company is headquartered in Redwood City, CA. | Fondateur | - |
| Xira Connect, Inc. | Directeur/Membre du Conseil | 01/08/2019 |
Anciens postes connus de Omid Farokhzad
| Sociétés | Poste | Fin |
|---|---|---|
| DYNC SPL | Président | 01/06/2022 |
| CARTESIAN THERAPEUTICS, INC. | Fondateur | 19/11/2019 |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | Fondateur | 01/01/2019 |
| ░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Omid Farokhzad
| Boston University School of Medicine | Doctorate Degree |
| MIT Sloan School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SEER, INC. | Health Technology |
| SENTI BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
Semaphore, Inc.
 Semaphore, Inc. Packaged SoftwareTechnology Services Part of Roper Technologies, Inc., Semaphore, Inc. develops and distributes advanced financial and project management software. The company is based in New York, NY. The company was founded by Omid C. Farokhzad. Semaphore was acquired by Deltek Systems, Inc. on August 10, 2000 for $10 million. | Technology Services |
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | Health Technology |
Placon Therapeutics, Inc.
Placon Therapeutics, Inc. BiotechnologyHealth Technology Placon Therapeutics, Inc. develops novel platinum therapies. The private company is based in Watertown. | Health Technology |
Dynamics Special Purpose Corp.
 Dynamics Special Purpose Corp. Financial ConglomeratesFinance Dynamics Special Purpose Corp. is a blank check company formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. The company was founded on March 1, 2021 and is headquartered in Redwood City, CA. | Finance |
| Xlink Therapeutics, Inc. | |
PrognomIQ, Inc.
PrognomIQ, Inc. Medical SpecialtiesHealth Technology PrognomIQ, Inc. operates as a healthcare company, which engages in the development and commercialization of multi-omics human tests for cancer and other complex diseases. It aims to leverage Seer’s Proteograph in addition to genomics and metabolomics technologies, to develop multi-omics products to improve human health. The company is headquartered in Redwood City, CA. | Health Technology |
| Xira Connect, Inc. | |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Health Services |
